beat therapeutics is driven by a strong commitment to transforming cancer treatment by turning genomic chaos into therapeutic control.
We are a drug discovery & development startup advancing first-in-class targeted therapies that disrupt cancer’s survival mechanisms at the DNA repair level, exploiting genomic instability as a selective vulnerability.
We aim to set new benchmarks in treatment efficacy, minimize side effects, and address the urgent unmet needs of patients with aggressive and treatment-resistant cancers.
Company Details
- Employees
- 8
- Founded
- 2023
- Address
- Rua Alfredo Allen 455, Porto,porto 4200-135,portugal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- IPLEXMED.
- HQ
- Porto, Porto
- Competitors
- Bluepharma, i3S - Instituto de Investigação e Inovação em Saúde, RISE - Health Research Network, Orgavalue, RYA Purification Technologies, AICIB - Agência de Investigação Clínica e Inovação Biomédica, CINTESIS - Center for Health Technology and Services Research, Biocant Park, FairJourney Biologics, IPLEXMED.
Beat Therapeutics Questions
Beat Therapeutics's LinkedIn profile is https://pt.linkedin.com/company/beat-therapeutics
Beat Therapeutics has
8 employees.
View email and phone details for 8
employees at Beat Therapeutics.
Beat Therapeutics's industry is
Biotechnology Research
Beat Therapeutics's top competitors are
Bluepharma,
I3s - Instituto De Investigação E Inovação Em Saúde,
Rise - Health Research Network,
Orgavalue,
Rya Purification Technologies,
Aicib - Agência De Investigação Clínica E Inovação Biomédica,
Cintesis - Center For Health Technology And Services Research,
Biocant Park,
Fairjourney Biologics,
Iplexmed.
Beat Therapeutics's categories are Biotechnology Research
Beat Therapeutics's founding year is 2023
